We have earlier established a positive correlation between PTEN mutations and mTORC2 hyperactivity, which negatively regulates GSK3β activity in GBM, and a connection between mTORC2 and Hh pathway in the context of GSK3β activity38. The gene discussed is GSK3B; the disease is glioblastoma.